Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Oxygen saturation decreased? 527 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 527 reports of Oxygen saturation decreased have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 4.0% of all adverse event reports for EPOPROSTENOL.

527
Reports of Oxygen saturation decreased with EPOPROSTENOL
4.0%
of all EPOPROSTENOL reports
136
Deaths
456
Hospitalizations

How Dangerous Is Oxygen saturation decreased From EPOPROSTENOL?

Of the 527 reports, 136 (25.8%) resulted in death, 456 (86.5%) required hospitalization, and 27 (5.1%) were considered life-threatening.

Is Oxygen saturation decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 527 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Oxygen saturation decreased?

TREPROSTINIL (3,865) RITUXIMAB (3,139) AMBRISENTAN (1,791) MACITENTAN (1,666) TOCILIZUMAB (1,501) METHOTREXATE (971) PREDNISONE (880) PACLITAXEL (833) ADALIMUMAB (813) SELEXIPAG (810)

Which EPOPROSTENOL Alternatives Have Lower Oxygen saturation decreased Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Oxygen saturation decreased Reports All Drugs Causing Oxygen saturation decreased EPOPROSTENOL Demographics